A simple ATTR-CM score to identify transthyretin amyloid cardiomyopathy burden in HFpEF patients.

Min YeXiao LiuZhenbang GuJunyi SunYugang DongYili ChenChen LiuZexuan WuWengen Zhu

Published in: European journal of clinical investigation (2023)

The simple ATTR-CM score identified an 18.9% ATTR-CM burden in HFpEF patients, and a higher ATTR-CM burden might predict adverse outcomes with moderate discriminatory abilities in HFpEF.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
heart failure
prognostic factors
peritoneal dialysis
risk factors
patient reported outcomes
patient reported